Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Epidermal growth factor receptor directed therapy in head and neck cancer.
Choong NW, Cohen EE. Choong NW, et al. Crit Rev Oncol Hematol. 2006 Jan;57(1):25-43. doi: 10.1016/j.critrevonc.2005.06.002. Epub 2005 Oct 3. Crit Rev Oncol Hematol. 2006. PMID: 16207530 Review.
Key signaling pathways and targets in lung cancer therapy.
Choong NW, Salgia R, Vokes EE. Choong NW, et al. Clin Lung Cancer. 2007 Feb;8 Suppl 2:S52-60. doi: 10.3816/clc.2007.s.002. Clin Lung Cancer. 2007. PMID: 17382025 Review.
Phase II study of sunitinib malate in head and neck squamous cell carcinoma.
Choong NW, Kozloff M, Taber D, Hu HS, Wade J 3rd, Ivy P, Karrison TG, Dekker A, Vokes EE, Cohen EE. Choong NW, et al. Invest New Drugs. 2010 Oct;28(5):677-83. doi: 10.1007/s10637-009-9296-7. Epub 2009 Aug 4. Invest New Drugs. 2010. PMID: 19649772 Clinical Trial.
Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer.
Choong NW, Mauer AM, Haraf DJ, Lester E, Hoffman PC, Kozloff M, Lin S, Dancey JE, Szeto L, Grushko T, Olopade OI, Salgia R, Vokes EE. Choong NW, et al. J Thorac Oncol. 2008 Sep;3(9):1003-11. doi: 10.1097/JTO.0b013e31818396a4. J Thorac Oncol. 2008. PMID: 18758303 Free PMC article. Clinical Trial.
Gefitinib response of erlotinib-refractory lung cancer involving meninges--role of EGFR mutation.
Choong NW, Dietrich S, Seiwert TY, Tretiakova MS, Nallasura V, Davies GC, Lipkowitz S, Husain AN, Salgia R, Ma PC. Choong NW, et al. Nat Clin Pract Oncol. 2006 Jan;3(1):50-7; quiz 1 p following 57. doi: 10.1038/ncponc0400. Nat Clin Pract Oncol. 2006. PMID: 16407879
Adjuvant and neoadjuvant therapy for early-stage non-small-cell lung cancer.
Choong NW, Vokes EE. Choong NW, et al. Clin Lung Cancer. 2005 Dec;7 Suppl 3:S98-104. doi: 10.3816/clc.2005.s.018. Clin Lung Cancer. 2005. PMID: 16384544 Review.
Therapeutic targeting of receptor tyrosine kinases in lung cancer.
Choong NW, Ma PC, Salgia R. Choong NW, et al. Expert Opin Ther Targets. 2005 Jun;9(3):533-59. doi: 10.1517/14728222.9.3.533. Expert Opin Ther Targets. 2005. PMID: 15948672 Review.
Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction.
Choong NW, Mauer AM, Haraf DC, Ferguson MK, Sandler AB, Kesler KA, Fishkin PA, Ansari RH, Wade J 3rd, Krauss SA, Sciortino DF, Posner MC, Kocherginsky M, Hoffman PC, Szeto L, Vokes EE. Choong NW, et al. Med Oncol. 2011 Dec;28 Suppl 1:S152-61. doi: 10.1007/s12032-010-9658-1. Epub 2010 Aug 21. Med Oncol. 2011. PMID: 20730572 Clinical Trial.
Expanding role of the medical oncologist in the management of head and neck cancer.
Choong N, Vokes E. Choong N, et al. CA Cancer J Clin. 2008 Jan-Feb;58(1):32-53. doi: 10.3322/CA.2007.0004. Epub 2007 Dec 20. CA Cancer J Clin. 2008. PMID: 18096865 Review.
Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
Choong NW, Vokes EE, Haraf DJ, Tothy PK, Ferguson MK, Kasza K, Rudin CM, Hoffman PC, Krauss SA, Szeto L, Mauer AM. Choong NW, et al. J Thorac Oncol. 2008 Jan;3(1):59-67. doi: 10.1097/JTO.0b013e31815e8566. J Thorac Oncol. 2008. PMID: 18166842 Free PMC article. Clinical Trial.
23 results
Jump to page
Feedback